Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Trial of the Safety and Efficacy of IGC-AD1 on Agitation in Participants With Dementia Due to Alzheimer's Disease

The purpose of this study is to assess the efficacy of the oral medication IGC-AD1, a THC-based (Delta-9-Tetrahydrocannabinol) formulation administered twice a…

Alzheimer DiseaseAgitation,PsychomotorCare Giving Burden+2 more

IGC Pharma, LLCNCT05543681